Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33628 | 122 | 44.1 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
261 | 3 | HELICOBACTER PYLORI//GASTROENTEROLOGY & HEPATOLOGY//HELICOBACTER | 44585 |
590 | 2 | GASTRIC ULCER//GASTROPROTECTION//SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 14172 |
33628 | 1 | PENTADECAPEPTIDE BPC 157//BPC 157//STABLE GASTRIC PENTADECAPEPTIDE BPC 157 | 122 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PENTADECAPEPTIDE BPC 157 | authKW | 8259625 | 27% | 100% | 33 |
2 | BPC 157 | authKW | 5766718 | 20% | 96% | 24 |
3 | STABLE GASTRIC PENTADECAPEPTIDE BPC 157 | authKW | 3253792 | 11% | 100% | 13 |
4 | GASTRIC PENTADECAPEPTIDE BPC 157 | authKW | 1001167 | 3% | 100% | 4 |
5 | PEPTIDE BPC | authKW | 1001167 | 3% | 100% | 4 |
6 | PHARMACOL PATHOL | address | 571591 | 11% | 18% | 13 |
7 | BODY PROTECTION COMPOUND | authKW | 500583 | 2% | 100% | 2 |
8 | DIRECT CYTOPROTECTIVE EFFECT | authKW | 500583 | 2% | 100% | 2 |
9 | GASTRODUODENAL ANTIULCER AGENTS | authKW | 500583 | 2% | 100% | 2 |
10 | NEW GASTRIC JUICE PEPTIDE BPC | authKW | 500583 | 2% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Physiology | 932 | 30% | 0% | 37 |
2 | Pharmacology & Pharmacy | 422 | 35% | 0% | 43 |
3 | Neurosciences | 83 | 17% | 0% | 21 |
4 | Gastroenterology & Hepatology | 75 | 8% | 0% | 10 |
5 | Medicine, Research & Experimental | 56 | 9% | 0% | 11 |
6 | Dermatology | 16 | 3% | 0% | 4 |
7 | Critical Care Medicine | 14 | 2% | 0% | 3 |
8 | Orthopedics | 12 | 3% | 0% | 4 |
9 | Endocrinology & Metabolism | 6 | 4% | 0% | 5 |
10 | Surgery | 3 | 5% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL PATHOL | 571591 | 11% | 18% | 13 |
2 | CLIN THORAC SURG JORDANOVAC | 333721 | 2% | 67% | 2 |
3 | DIS POULTRY | 250292 | 1% | 100% | 1 |
4 | PHARM ALLIED HLTH PROFESS MED CHEM SECT | 250292 | 1% | 100% | 1 |
5 | GEN HOSP DR J KAJFES | 83429 | 1% | 33% | 1 |
6 | CLIN HOSP DR M STOJANOVIC | 62571 | 1% | 25% | 1 |
7 | HOSP SVETI DUH | 62571 | 1% | 25% | 1 |
8 | PHARMACOL PHARMACOTHER EUT | 16684 | 1% | 7% | 1 |
9 | GEN PATHOL PATHOL MORPHOL | 9625 | 1% | 4% | 1 |
10 | PHARMACOL | 6824 | 54% | 0% | 66 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHYSIOLOGY-PARIS | 80098 | 15% | 2% | 18 |
2 | JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 12060 | 8% | 0% | 10 |
3 | INFLAMMOPHARMACOLOGY | 1812 | 1% | 1% | 1 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1742 | 11% | 0% | 14 |
5 | JOURNAL OF PHARMACOLOGICAL SCIENCES | 1716 | 3% | 0% | 4 |
6 | CURRENT PHARMACEUTICAL DESIGN | 1006 | 4% | 0% | 5 |
7 | REGULATORY PEPTIDES | 844 | 3% | 0% | 4 |
8 | JOURNAL OF ORTHOPAEDIC RESEARCH | 750 | 3% | 0% | 4 |
9 | DIGESTIVE DISEASES AND SCIENCES | 701 | 5% | 0% | 6 |
10 | PHYSIOLOGY | 532 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SIKIRIC, P , SEIWERTH, S , RUCMAN, R , TURKOVIC, B , ROKOTOV, DS , BRCIC, L , SEVER, M , KLICEK, R , RADIC, B , DRMIC, D , ET AL (2011) STABLE GASTRIC PENTADECAPEPTIDE BPC 157: NOVEL THERAPY IN GASTROINTESTINAL TRACT.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 16. P. 1612-1632 | 62 | 90% | 9 |
2 | SIKIRIC, P , SEIWERTH, S , RUCMAN, R , KOLENC, D , VULETIC, LB , DRMIC, D , GRGIC, T , STRBE, S , ZUKANOVIC, G , CRVENKOVIC, D , ET AL (2016) BRAIN-GUT AXIS AND PENTADECAPEPTIDE BPC 157: THEORETICAL AND PRACTICAL IMPLICATIONS.CURRENT NEUROPHARMACOLOGY. VOL. 14. ISSUE 8. P. 857 -865 | 57 | 83% | 0 |
3 | SIKIRIC, P , SEIWERTH, S , RUCMAN, R , TURKOVIC, B , ROKOTOV, DS , BRCIC, L , SEVER, M , KLICEK, R , RADIC, B , DRMIC, D , ET AL (2013) TOXICITY BY NSAIDS. COUNTERACTION BY STABLE GASTRIC PENTADECAPEPTIDE BPC 157.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 1. P. 76-83 | 66 | 71% | 4 |
4 | SKORJANEC, S , KOKOT, A , DRMIC, D , RADIC, B , SEVER, M , KLICEK, R , KOLENC, D , ZENKO, A , BENCIC, ML , HALLE, ZB , ET AL (2015) DUODENOCUTANEOUS FISTULA IN RATS AS A MODEL FOR "WOUND HEALING-THERAPY" IN ULCER HEALING: THE EFFECT OF PENTADECAPEPTIDE BPC 157, L-NITRO-ARGININE METHYL ESTER AND L-ARGININE.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 66. ISSUE 4. P. 581 -590 | 44 | 73% | 4 |
5 | SIKIRIC, P , SEIWERTH, S , RUCMAN, R , TURKOVIC, B , ROKOTOV, DS , BRCIC, L , SEVER, M , KLICEK, R , RADIC, B , DRMIC, D , ET AL (2012) FOCUS ON ULCERATIVE COLITIS: STABLE GASTRIC PENTADECAPEPTIDE BPC 157.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 1. P. 126-132 | 42 | 79% | 13 |
6 | SIKIRIC, P , SEIWERTH, S , RUCMAN, R , TURKOVIC, B , ROKOTOV, DS , BRCIC, L , SEVER, M , KLICEK, R , RADIC, B , DRMIC, D , ET AL (2014) STABLE GASTRIC PENTADECAPEPTIDE BPC 157-NO-SYSTEM RELATION.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 7. P. 1126-1135 | 58 | 53% | 2 |
7 | DJAKOVIC, Z , DJAKOVIC, I , CESAREC, V , MADZARAC, G , BECEJAC, T , ZUKANOVIC, G , DRMIC, D , BATELJA, L , SEVER, AZ , KOLENC, D , ET AL (2016) ESOPHAGOGASTRIC ANASTOMOSIS IN RATS: IMPROVED HEALING BY BPC 157 AND L-ARGININE, AGGRAVATED BY L-NAME.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 22. ISSUE 41. P. 9127 -9140 | 42 | 71% | 0 |
8 | LOJO, N , RASIC, Z , SEVER, AZ , KOLENC, D , VUKUSIC, D , DRMIC, D , ZORICIC, I , SEVER, M , SEIWERTH, S , SIKIRIC, P , (2016) EFFECTS OF DICLOFENAC, L-NAME, L-ARGININE, AND PENTADECAPEPTIDE BPC 157 ON GASTROINTESTINAL, LIVER, AND BRAIN LESIONS, FAILED ANASTOMOSIS, AND INTESTINAL ADAPTATION DETERIORATION IN 24 HOUR-SHORT-BOWEL RATS.PLOS ONE. VOL. 11. ISSUE 9. P. - | 33 | 89% | 0 |
9 | KLICEK, R , KOLENC, D , SURAN, J , DRMIC, D , BRCIC, L , ARALICA, G , SEVER, M , HOLJEVAC, J , RADIC, B , TURUDIC, T , ET AL (2013) STABLE GASTRIC PENTADECAPEPTIDE BPC 157 HEALS CYSTEAMINE-COLITIS AND COLON-COLON-ANASTOMOSIS AND COUNTERACTS CUPRIZONE BRAIN INJURIES AND MOTOR DISABILITY.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 64. ISSUE 5. P. 597-612 | 43 | 65% | 10 |
10 | SIKIRIC, P , SEIWERTH, S , BRCIC, L , SEVER, M , KLICEK, R , RADIC, B , DRMIC, D , ILIC, S , KOLENC, D , (2010) REVISED ROBERT'S CYTOPROTECTION AND ADAPTIVE CYTOPROTECTION AND STABLE GASTRIC PENTADECAPEPTIDE BPC 157. POSSIBLE SIGNIFICANCE AND IMPLICATIONS FOR NOVEL MEDIATOR.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 10. P. 1224-1234 | 40 | 68% | 11 |
Classes with closest relation at Level 1 |